Loading viewer...
report
Format: PDF report
This report details the development and clinical evaluation of BIO89-100, a novel FGF21 analog for treating NASH and severe hypertriglyceridemia.
presentation
report
Starcom Information Technology Limited
report
Svea Bank
report
Jaguar
report
Emera